HE astrocyte is a central nervous system (CNS)-specific cell type derived embryologically from a primitive neuroepithelial stem cell within the ependymal zone. This stem cell differentiates into an astrocyte as it migrates radially from the neuroepithelium to reside ultimately in the parenchyma of the brain. 62 In the adult human brain, normal astrocytes constitute nearly 40% of the total CNS cell population and may assume a star-shaped configuration resembling epithelial cells insofar as the astrocytes remain intimately associated, through their cytoplasmic extensions, with the basement membrane of the capillary endothelial cells and the basal lamina of the glial limitans externa. Almost the entire surface of the CNS is covered by a layer of astrocytic processes interposed between the brain parenchyma and the pial membrane. When the extreme convolution of the CNS and the richness of its vascular bed are taken into consideration, the lush extent of this peripheral astrocytic expansion is truly remarkable. Although their exact function remains unknown, astrocytes probably subserve an important supportive role for neurons, providing a favorable ionic environment, modulating extracellular levels of neurotransmitters, and serving as spacers that organize neurons.
in experimental models of cerebral trauma using cryogenic lesions and stab wounds. 67, 72, 112, 113 Evidence exists that the local activation of astrocytes in these models is mediated by cytokines and growth factors including interleukin (IL)-1, IL-6, transforming growth factor-␣, transforming growth factor-␤1, tumor necrosis factor-␣, ␥-interferon, and basic fibroblast growth factor. 2, [31] [32] [33] 40, 53, 58, 82, 119, 120 Interestingly, astrocytes have the highest predisposition to malignant transformation of any CNS cell type. The astrocytoma is the most common brain tumor arising in the CNS, accounting for 65% of all primary brain tumors. The majority of astrocytomas are histologically malignant neoplasms. Astrocytomas are also the most common neoplasm among the childhood brain tumors. Although the majority of astrocytomas in children may not be histologically malignant, nonetheless they frequently cause serious morbidity because of their location in vital areas of the brain, such as the brainstem, optic nerves, and pineal region. No direct cause for the development of astrocytomas in either children or adults has been found. Although there is a body of circumstantial evidence linking these tumors to trauma, prior irradiation, viral infections, and environmental and nutritional factors, clear-cut evidence implicating any one of these is lacking.
The malignant astrocytoma is a highly invasive neoplasm infiltrating diffusely into regions of normal brain, rendering total surgical extirpation impossible and effective local radiation therapy difficult. For poorly understood reasons, malignant astrocytomas rarely give rise to systemic metastases. 103 Rather, tumor progression and death are the result of unremitting local disease. Histopathologically, the malignant astrocytoma is a highly anaplastic and heterogeneous tumor. Although the histogenesis of the malignant astrocytoma is not well understood, there are data to indicate that a malignant astrocytoma may either derive from a less malignant precursor astrocytoma 59 or, more commonly, arise de novo from a cytogenetically perturbed normal astrocyte. In immunohistochemical preparations, normal, reactive, and neoplastic astrocytes may be positively identified and distinguished from other CNS cell types by the expression of glial filaments that are supramolecular filamentous networks comprised of glial fibrillary acidic protein (GFAP) (Fig. 1 ).
Intermediate Filaments: Classification and Structure
The cytoskeleton of eukaryotic cells is composed of three major protein networks: 1) the 6-nm-diameter actin microfilaments; 2) the 20-nm-diameter microtubules; and 3) the intermediate filaments (IFs) that range in diameter from 8 to 12 nm, so named because they are intermediate in size between the actin microfilaments and the microtubules. In contrast to the evolutionarily conserved actin and microtubule proteins, IF proteins are highly diverse and exhibit cell type specificity of expression. Intermediate filament gene expression is also tightly coordinated with organ development and tissue differentiation. Accordingly, IFs provide valuable tools with which to study cell determination and differentiation.
On the basis of amino acid sequence homologies and intron positions, IFs can be subdivided into at least six principal types. 34 Keratins are the sole members of the Type I (acidic) and Type II (basic) classes. Vimentin, desmin, GFAP, and peripherin are designated as Type III IF proteins, sharing more than 70% sequence homology (Fig. 2) . The neurofilament proteins are composed of light, medium, and heavy chain proteins and, together with ␣-internexin, are classified as Type IV IFs. Lamin is the only example of a Type V IF. A new IF protein, called nestin, which is clearly a member of the IF superfamily, based on sequence and structure analyses, and which has been localized to neuroepithelial stem cells early in neuroembryogenesis, has been described and classified as a Type VI IF.
61
Glial Fibrillary Acidic Protein: a Marker for Cells and Tumors of Glial Origin Glial fibrillary acidic protein is a 50-kD intracytoplasmic filamentous protein that constitutes a portion of, and is specific for, the cytoskeleton of the astrocyte. This GFAP shares considerable structural homology with the other IFs in the central ␣-helical or rod domain. 60 In sharp contrast to this highly conserved central rod domain, the NH 2 -and COOH-terminal regions of all IFs have distinct amino acid sequences and widely divergent structural features (Fig. 2) . 60, 83, 109 Because of the variability in the NH 2 -terminal segment among the several classes of IFs, this segment has been presumed to participate in the regulato-ry functions of these proteins. In the case of GFAP, all four amino acid residues in the NH 2 -terminal region that undergo phosphorylation are located here (see discussion of phosphorylation in Posttranslational Modifications in GFAP). 47 First isolated from white matter plaques of patients with longstanding multiple sclerosis, 29 GFAP is the most widely used marker for cells of astrocytic origin under normal and pathological conditions. 20, 21 Highly specific polyclonal antibodies to human GFAP have been available since approximately 1975, and application of these antibodies to immunohistochemical studies in the CNS have been extremely helpful in determining brain response to injury and in refining tumor diagnosis. 20, 21 That notwithstanding, GFAP immunohistochemistry may lead to variable results depending on the type of antiserum used (polyclonal antisera vs. monoclonal antibodies), shelf life of the primary antiserum used, type of fixative, interval of fixation, and embedding medium selected. 69 McLendon, et al., 70 and Pegram and colleagues 85 have shown that monoclonal antibodies reacting to different epitopes of GFAP can be combined to enhance the specificity and sensitivity of GFAP immunostains in fixed tissue sections.
Interestingly, with increasing astrocytic malignancy, there is progressive loss of GFAP production. 20, 21, 25, 26, 28, 50 By immunohistochemical analysis, malignant astrocytomas are shown to have fewer tumor cells that stain positively and intensely for GFAP than do less malignant astrocytomas and normal brain specimens. 26, 28 For these reasons, GFAP has been considered a reliable marker of differentiation in normal astrocytes and tumors of astrocytic lineage. It is also well accepted, however, that GFAP may be found much less commonly in CNS tumor cells that, although neuroepithelial in origin, are not strictly speaking astrocytic, including the oligodendroglioma, ependymoma, primitive neuroectodermal tumor, and choroid plexus papilloma. 19, 56, 65, 73, 77, 92, 95 In these tumor types, care must be taken to distinguish between GFAP-positive neoplastic cells and entrapped or peritumoral reactive astrocytes, both of which express abundant GFAP. 19, 77 Interestingly, GFAP may be expressed in cells outside the CNS, such as nonmyelinating Schwann cells, the epithelium of the lens, the epithelial cells of salivary glands and their neoplasms, and neoplastic cells of mullerian origin. 95 
Molecular Biology of GFAP
The amino acid sequence of human GFAP has been deduced from the nucleotide sequence of complementary (c)DNA clones encoding this protein. 9, 12, 90 Mouse and human GFAP genomic genes have also been cloned and sequenced. 3, 63, 80 There is high homology among rat, mouse, and human GFAP in the coding regions of the gene, but less so in the 3Ј untranslated region. As such, GFAP shows 90 to 95% homology between species. 10 Bongcam-Rudloff, et al., 9 have used Southern blot hybridization of somatic cell hybrids and in situ hybridization to assign the chromosomal location of the human GFAP gene to chromosome 17 (17q21). Mapping studies indicate that GFAP is part of a large syntenic gene cluster including at least 22 genes located on chromosome 17 57 ( Fig. 3) .
Transcriptional Regulation of the GFAP Gene. Proteinencoding mammalian genes frequently contain a basal promoter region with DNA sequences that guide the transcription of the gene by assembling RNA polymerase II and other general transcription factors. In most mammalian genes, the repeated DNA nucleotide sequence of thymidine-adenosine-thymidine-adenosine (or "TATA" sequence) is found 29 to 33 bp upstream of the RNA start site. This TATA box binds general transcription factor IID, which is essential for the transcription of the gene from On the basis of amino acid sequence homologies, the IFs can be subdivided into six principal types as shown. Whereas the head and tail domains of the IF subtypes vary considerably and provide the basis, in part, for their tissue-specific expression, there is considerable homology within the central rod domain, which is composed of interconnected protein segments forming ␣-helical coils. Glial fibrillary acidic protein is a Type III IF along with vimentin, desmin, and peripherin. In the CNS, neurofilaments provide structural integrity for neuronal axons. Nestin, the newest member of the IF family, is expressed in embryonic stem cells during neuroembryogenesis. DNA to messenger (m)RNA. Nakatani and associates 80 showed that GFAP has a basal promoter sequence with the "TAT" motif 29 bp from the RNA start site (Fig. 4) .
In addition to transcriptional regulation by basal promoter sequences such as TATA, the pattern of expression for a gene is also controlled in part by other DNA sequences that activate or inhibit transcription. Sequences that activate gene transcription are called "enhancers," whereas those that inhibit gene transcription are called "silencers." These sequences are typically found within 1 to 2 kb upstream of the RNA start site, but may be located further upstream or downstream depending on the tertiary or quaternary structure of the gene. In general, gene enhancers or silencers achieve their effects by binding proteins that interact directly with the basal transcriptional machinery or indirectly through intermediary proteins. The results from a number of laboratories now show that gene enhancer or positive regulatory regions of the GFAP gene exist between Ϫ250 and Ϫ80 bp and between Ϫ1980 and Ϫ1500 bp, 10 and a gene silencer or negative regulatory region is found at Ϫ650 to Ϫ360 bp (Fig.  4) . Within its positive regulatory region, the human GFAP promoter contains transcription factor-binding sites for the cyclic adenosine monophosphate (cAMP)-responsive element-binding protein, Sp-1, NF-1, AP-1, and AP-2 transcription factors. 4 These transcription factors are among the first proteins induced by many stimuli and mediate some of the changes in gene regulation induced by hormones, growth factors, and antigens. As one example, the ILs, which are released during brain inflammatory responses, lead to increased levels of c-jun and c-fos. These early response genes have been shown to bind to the AP-1 binding site on the GFAP promoter, indicating that one of the effects of cytokine expression may be increased GFAP transcription. 58 The promoter region of the GFAP gene also contains DNA sequence information that confers glial cell-associated expression to cells of the CNS, namely the astrocytes. As for the sequence of the GFAP promoter that controls glial cell-associated expression, there has been some debate among different laboratories. However, a consensus sequence for glial cell-specific expression has been located in the positive regulatory region of the human GFAP promoter and has been termed the human GFAP consensus sequence, or "hgcs." 4, 66 At the present time, a yetto-be-determined transactivating protein(s) binds this sequence and enhances GFAP transcription. Once identified, this protein, which specifically binds to the GFAP promoter and enhances glial cell-specific expression, may be used with the GFAP promoter that is linked to other genes of interest in neurobiology or neurooncology to express them specifically in astrocytes in culture or in transgenic animals (see following subsection). The information obtained from such studies could conceivably lead to interventions in brain disorders during neural development, brain injury, and glial tumorigenesis.
Glial 4 . Model of the GFAP promoter including the region 2 kb upstream from the initiation start site. In addition to transcriptional regulation by basal promoter sequences such as "TATA" and "CAAT," expression of the GFAP gene is controlled, in part, by positive regulatory elements between Ϫ250 and Ϫ80 bp and between Ϫ1980 and Ϫ1500 bp, and a negative regulatory region at Ϫ650 to Ϫ360 bp. Within the positive regulatory region, the human GFAP promoter contains transcription factor binding sites for the cAMP responsive element binding protein, NF-1, AP-1, and AP-2 transcription factors. These transcription factors are among the first proteins induced by many stimuli and mediate some of the changes in gene regulation induced by hormones, growth factors, and antigens. The positive regulatory region between Ϫ1980 and Ϫ1500 bp also contains DNA sequence information that confers glial cell-specific expression of GFAP. This sequence has been termed the human GFAP consensus sequence (hgcs).
been enhanced significantly since the development of transgenic mouse technology, in which a gene encoding the protein of interest can be microinjected into a developing mouse embryo (Fig. 5) . Once born, the mouse displays the phenotype of the protein, which may be expressed either ectopically or in excess. The first reported transgenic study using the GFAP gene was reported by Mucke, et al. 76 In that report and in several others that followed, 11 the promoter region of the GFAP gene was found to direct the activity of a reporter gene in cells of the CNS with little, if any, expression in other organs. As one example, Campbell, et al., 14 used a GFAP-transgene cassette to express IL-6 in mouse brain astrocytes. The transgenic mouse offspring were found to have stunted growth, ataxia, and seizures. Neuropathological examination of these animals revealed loss of, and damage to, neurons and dendrites, marked astrogliosis, and some neovascularization. 14 The induction of acute-phase proteins by IL-6 was thought to be responsible for the immunological responses observed in the CNS. In another study, Toggas and colleagues 114 created transgenic mice from a construct in which the human immunodeficiency virus-1 coat was attached to the GFAP promoter. In these mice, considerable neuronal damage was found on neuropathological examination. 114 Finally, a study by Galou, et al., 35 showed that a 2-kb fragment of the 5Ј flanking region of the murine GFAP gene linked to a ␤-galactosidase reporter gene was activated following a stab wound to the brain in transgenic mice. These transgenic lines may thus provide a useful tool to study certain aspects of reactive astrocytosis. In all the studies just described, the ability of GFAP DNA regulatory sequences to target expression of transgenes to cells of glial origin opens exciting opportunities to influence the behavior of astrocytes or to target tumors of astrocytic origin.
Posttranslational Modifications in GFAP. The authentic message (mRNA) of the GFAP gene is 3.5 kb and is known as the standard form or GFAP-␣. Alternate forms of GFAP mRNA have been described and have been termed GFAP-␤ and GFAP-␥. 10 The GFAP-␤ mRNA was first described in the ethylnitrosourea-induced Schwann cell line, RT4-D6. 43 In the peripheral nervous system, GFAP-␤ mRNA may be the predominant form of GFAP, whereas GFAP-␣ mRNA is the predominant form in the CNS. 10 The GFAP-␥ mRNA has been found in both CNS and non-CNS tissues including mouse bone marrow and spleen. 10 At this time, relatively little is known about the function and role of the alternate forms of GFAP mRNA in terms of protein formation. After the mRNA is translat-FIG. 5. Strategy for CNS gene targeting using the GFAP promoter sequence in transgenic mice. To obtain a gene expressed specifically in the brain, the gene of interest is placed in a DNA construct along with 2.5 kb of the GFAP promoter. The construct is then microinjected into fertilized mouse ova at the two-to fourcell stage. The developing mouse embryos are then implanted into pseudopregnant mice and allowed to develop to term. Once born, the transgenic mouse will express the gene of interest exclusively in glial cells of the CNS. In this way, the GFAP promoter has provided targeting specific sequences for the foreign gene to be expressed in the brain. Such targeting strategies using the GFAP promoter may ultimately prove useful in CNS gene therapy trials in humans.
FIG. 6. Regulation of GFAP assembly and disassembly. Two GFAP molecules unite to form a GFAP dimer that takes the shape of an ␣-helical coil. Two GFAP dimers unite to form a tetramer of antiparallel protofilaments. Multiple tetramers assemble eventually to form the typical 10-nm IF bundles that are readily appreciated by electron microscopy. The 10-nm IF bundles are dynamic structures that shift between assembled and disassembled states. The phosphorylation of amino acid residues in the NH 2 -terminal region of GFAP by various kinases, including cdc2, leads to disassembly of GFAP filaments into a soluble form. Phosphatases can then act on the soluble form of GFAP to cleave phosphorylated residues, leading to the return to the insoluble form of GFAP as shown.
ed into protein, however, GFAP undergoes posttranslational modifications, including blocking of the methionine at the NH 2 terminus and phosphorylations. Of these, the phosphorylation of GFAP plays a pivotal role in GFAP structure and function.
Phosphorylation of a protein on serine, threonine, or tyrosine residues is a common posttranslational modification that allows for rapid and reversible alterations in protein conformation and function. Just as with other IFs and cytoskeletal proteins, GFAP does not exist in one static form. Rather, there is a continuous and dynamic shift from an assembled (filamentous) state to a disassembled (soluble) state. 48, 49, 79 In particular, phosphorylation of a number of IFs has been observed to occur during mitosis. Phosphorylation at this time point in the cell cycle may assist with the reorganization of GFAP that occurs during mitosis. 17, 18, 48, 68 It is currently believed that phosphorylation in the NH 2 -terminal region of GFAP is important for disassembly from a filamentous form into a soluble form (Fig. 6) . 1, 47, 78, 80 This disassembly of the filamentous protein likely facilitates equal separation of cytoplasmic components into two daughter cells during cytokinesis.
Proof that the NH 2 -terminal head region is indispensable for GFAP filament formation comes from a variety of different studies. 48, 89 In one study, cleavage of the NH 2 terminus of GFAP by thrombin digestion led to failure of GFAP assembly. 89 In other studies, serine and threonine residues in the NH 2 -terminal region of GFAP act as in vitro substrates for phosphorylation by a number of protein kinases including the cyclin-dependent kinase cdc2 (cdk1), cAMP-dependent kinase, Ca ++ -calmodulin-dependent kinase II, and protein kinase C. 48 The NH 2 -terminal phosphorylation of GFAP by these kinases promotes disassembly of already assembled glial filaments. At this time, it is not known precisely which phosphorylation sites on GFAP and which protein kinases are critical for GFAP disassembly. One report suggests that cdc2 activity alone is not sufficient for mitotic disassembly in vitro, but that a Ca ++ -calmodulin-dependent kinase is the critical enzyme. 115 Although cdc2 phosphorylates GFAP on a single serine-8 residue, Ca ++ -calmodulin-dependent kinase phosphorylates GFAP on serines 13, 17, and 34. 115 It is conceivable that different protein kinases play roles in the reorganization of the astrocyte's cytoskeleton in response to a variety of stimuli. 122 In addition, the sequential activation of different protein kinases that phosphorylate different protein residues on GFAP may be critical to the process of glial filament disassembly in mitosis. When antibodies to different phosphorylated peptide regions of the NH 2 terminus of GFAP were used to study GFAP expression, there was a difference in the expression of phosphorylated GFAP epitopes at the G 2 -mitosis transition and during cytokinesis. 81 These investigators have suggested that there may be two different mitotic GFAP kinases: cdc2, which acts first at the G 2 -M transition, followed by a yet-to-be-identified kinase, which acts during cytokinesis.
From these data it is apparent that phosphorylation of GFAP in the NH 2 -terminal domain is an important means of regulating GFAP assembly and disassembly. Glial fibrillary acidic protein is also phosphorylated at sites outside the head domain, but the significance of these phosphorylation sites is unknown. A better understanding of the role glial filaments play in the cytoskeleton of astrocytes will undoubtedly emerge soon from further studies that examine the sites and timing of GFAP phosphorylations.
In Search of the Function of GFAP Glial Fibrillary Acidic Protein-Cytoskeleton Interactions.
Despite the wealth of information now available concerning the IF family, we still know very little about the role that GFAP subserves in astrocytes and astrocytic tumors. Glial fibrillary acidic protein is thought to stabilize the astrocyte's cytoskeleton and to maintain astrocyte cell shape through interactions between GFAP filaments, the nuclear membrane, and the plasma membrane. 39 This statement is further supported by immunoelectron microscopy data that show abundant GFAP filaments at sites of contact between astrocytic processes and neurons, endothelial or leptomeningeal basal laminae. 93 Thus, GFAP forms a structural link between the nucleus and the plasma membrane.
The aforementioned physical interactions are likely mediated through a panoply of putative IF-associated proteins (IFAPs), 30, 39, 117, 118 but the details of these interactions have yet to be fully characterized. Yang and associates 121 have recently described an essential cytoskeletal linker protein connecting neurofilaments to actin microfilaments. Mice deficient in this linker protein, termed BPAG1n, will undergo sensory neurodegeneration and will demonstrate a dystonia musculorum phenotype. 121 These authors have suggested that BPAG1n is vitally important for the neuron and the host and that severing the connections between the neurofilaments and actin microfilaments may adversely affect axonal transport mechanisms. 121 A different example of an IFAP that binds to GFAP to aid in cytoskeletal support is plectin. Plectin is a 300-kD protein first identified in the rat C6 astrocytoma cell line. 88 Part of plectin's primary sequence is related to desmoplakin and bullous pemphigoid antigen. Plectin has been shown to bind to several IFs and has been found in virtually all cell types. Plectin colocalizes with IFs at focal contact and actin stress fiber sites (Fig. 7) . 105 Using immunoelectron microscopy, Bohn, et al., 8 recently showed that vimentin IFs were structurally linked to actin microfilaments through thin (3-nm) connecting filaments similar in size to plectin. In cosedimentation experiments, however, plectin has not been shown to bind to F-actin directly. 105 Accordingly, it has been suggested that plectin may connect with actin filaments through actin-binding proteins. 105 Examples of well-characterized actin-binding proteins include actinin, talin, and vinculin. Interestingly, these actin-binding proteins are known to bind to the short cytoplasmic domains of the main mediators of cell-extracellular matrix (ECM) adhesion-the integrins (see following subsection).
Glial Fibrillary Acidic Protein: a Link to Glial Cell Adhesion?
We previously observed that treatment of a GFAPpositive cell line, U-251MG, with antisense GFAP led to a marked reduction in cell adhesion. 100 The observations that IFs link to actin filaments by means of actin-binding proteins and that actin is linked to the cytoplasmic domains of integrins by virtue of these same actin-binding proteins suggest that actin and, to a lesser extent, GFAP are physically linked to the plasma membrane and will respond together to changes in cell morphology or the cellular microenvironment (Fig. 8) . Integrins have been colocalized immunocytochemically with actin-containing microfilaments, and biochemical evidence has been obtained to indicate a direct binding of integrin cytoplasmic domains to certain cytoskeletal proteins, including talin and ␣-actinin, at sites of contact between the cells and their substrata. The integrins are a family of Type I transmembrane proteins composed of a large extracellular domain, a hydrophobic membrane spanning segment, and a short cytoplasmic domain. 46, 94, 105 Each integrin is composed of an ␣ and a ␤ subunit. At present, there are at least 15 different ␣ and nine ␤ subunits that can variously combine to form 21 receptors with distinct ligand specificities. 36 Integrins recognize specific peptide regions within ECM macromolecules, the best characterized of which is the arginine-glycine-aspartic sequence of fibronectin. [22] [23] [24] 94 A relationship between IFs and integrins has recently been elucidated via the molecular characterization of the hemidesmosome that contains keratin IFs linked to the ␣6␤4 integrin through the bullous pemphigoid antigen. 16, 36, 110 It has been proposed that a reduction in integrin expression, as seen in many instances in transformed cells, leads to the dissociation of the ECM and the cytoskeleton, resulting in reduced adhesion and cytoskeletal disorganization. 22, 87 On binding to extracellular ligands, integrins cluster on the plane of the plasma membrane and promote the assembly of molecular complexes containing both cytoskeletal and signaling elements. 36, 104 The effects that the ECM has on cellular growth and differentiation are likely mediated through various integrin signaling pathways (socalled "out/in" signaling). Although the integrin signaling pathways have not been completely characterized, many involve tyrosine kinase phosphorylation of neighboring protein species and cyclin-dependent kinases. 6, 44, 102, 111 As one example, the study of ECM-induced aggregation of integrin receptors at focal adhesion sites led to the identification of a phosphorylated 125-kD protein known as focal adhesion kinase (FAK). 44, 102 This FAK has been shown to associate physically with two nonreceptor protein tyrosine kinases, pp60src and pp59fyn, via their Src homology 2 domains. 102 Interestingly, a number of recent studies have shown that induced changes in the cytoskeleton are also likely to perturb integrin-mediated signaling (so-called "in/out" signaling) (Fig. 8) . 37, 91 Glial Fibrillary Acidic Protein and Signaling Pathways. In general, the progression of a cell through the cell cycle is ultimately controlled by a series of protein kinases whose activities are regulated by a group of proteins called cyclins. The cyclin-dependent protein kinases (cdks) phosphorylate key substrates that are required to facilitate the passage of the cell through each phase of the cell cycle. Two important regulatory points exist in the cell cycle: one at the G 2 -M interphase and the other at the G 1 -S interphase. The protein kinase cdc2 interacts with cyclin B and cyclin A to regulate mitosis, and cdk2 interacts with a variety of cyclins (D1, D2, D3, E, and A) to regulate progression through the G 1 phase and DNA synthesis. 107 Intrinsic alterations of cell cycle genes and their expression have now been identified in a wide variety of human cancers. 71, 75 As examples, overexpression and amplification of cyclin D1 has been demonstrated in human parathyroid adenoma, leukemia, lymphoma, esophageal carcinoma, and breast carcinoma. cell lines, with mitotic cyclins appearing prior to G 1 cyclins. In addition, overexpression of cyclin A has been shown to be associated with anchorage-independent cell growth, another hallmark of cancer cells in vitro. 42 There has been one previous report on the interaction of cyclindependent kinases and IFs. 108 In that paper, the activation of p34cdc2 coordinated the mitotic reorganization of the vimentin IF network both by severing IF-IF connections mediated by IFAPs and by disassembling individual IFs into protofilaments. Because there are now reports that link IFs and integrins to cell cycle gene expression, 42, 111 future experiments in this field will undoubtedly clarify the role of GFAP in complex cellular responses such as process formation, cell adhesion, and cell motility.
Lessons Learned From Modulating GFAP Expression.
Clues as to the function of glial filaments in normal human astrocytes and glial tumors have come from a number of studies in which GFAP expression has been modulated under experimental conditions. It is known that early in neuroembryogenesis, astrocytes may synthesize vimentin instead of GFAP as their primary IF. 7, 109 The switch to GFAP predominance occurs prenatally in human astrocytes and is caused by factors that have yet to be elucidated. In vitro, cultured astrocytes modulate GFAP synthesis in response to cell density, 38 composition of growth media, 74 and hormones that stimulate cAMP production. 106 Because GFAP is a cytoskeletal element that appears to play an important role in astrocytic differentiation and because it is the most specific marker for cells of astrocytic lineage, several groups have studied how the modulation of GFAP expression might affect astrocytoma growth and differentiation. In an earlier study, all-trans and 13-cis retinoic acid (10 Ϫ6 M) were effective in decreasing the proliferation of GFAP-positive U-343MG-A astrocytoma cells and in increasing the amount of GFAP produced, as measured by an enzyme-linked immunosorbent assay. 97 In another study, it was shown that ECM proteins derived from normal human leptomeningeal cells effectively stopped the proliferation of U-343MG-A astrocytoma cells and induced differentiation of these cells as calculated by a quantitative increase in cellular GFAP. 96, 98 The results from these studies suggest that the upregulation of GFAP in GFAP-positive astrocytoma cells is associated with alterations in astrocytoma growth and morphology.
However, as the vast majority of human astrocytoma cell lines are GFAP negative and, consequently, similar to highly anaplastic astrocytomas in vivo, 5, 15, 99, 116 a study was performed in which GFAP expression was restored to GFAP-negative anaplastic astrocytoma cells. A GFAPnegative human astrocytoma cell line, SF-126, was stably transfected with an expression vector containing a cDNA for the entire coding sequence of the human GFAP gene. 101 Interestingly, GFAP-immunoreactive SF-126 astrocytoma clones were characterized by elongated cytoplasmic processes containing high concentrations of GFAP and demonstrated marked alterations in cellular morphology when compared to controls. In addition, the amount of GFAP mRNA expression and immunoreactivity among stably transfected astrocytoma clones correlated inversely with astrocytoma proliferation. 101 Recently, studies have been performed in which the GFAP gene has been eliminated in transgenic "knockout" mice. 41, 64, 86 In two of these studies, GFAP-deficient mice appeared to develop and function normally, and in the areas of the brain subjected to detailed neuropathological study, no cytoarchitectural disturbances of the CNS of these mice have been found. 41, 86 Although these authors did not examine the long-term effects of GFAP deficiency on the mouse brain, they postulated that GFAP-deficient mice may be more prone to advanced CNS aging than normal mice. This postulate has now been proved correct by Liedtke, et al., 64 who showed that transgenic mice deficient in GFAP develop abnormal myelination in the spinal cord, optic nerve, and brain after 6 months. Ultrastructurally, the authors showed that astrocytic processes in GFAP-deficient mice were short and clublike, leading to reduced contacts between astrocytes and oligodendrocytes, and between astrocytes and myelin sheaths. 64 The altered myelination of the CNS in GFAP-deficient mice suggests an important link between astrocyte function and the maintenance of myelin. In addition, GFAP-deficient mice had poor white matter vascularization, which may have resulted from the loss of inductive influences of astrocytes on endothelial cells. 64 The implications from the study by Liedtke, et al., are profound because they suggest that for the CNS to retain structural and functional integrity with respect to CNS myelination, normal GFAP expression appears to be mandatory.
Conclusions
In summary, evidence is accumulating to suggest that GFAP may be involved as a collaborator in the complex cellular processes controlling astrocytoma cell morphology, adhesion, and proliferation. Glial fibrillary acidic protein may not represent a mere mechanical integrator of cellular space as has been previously thought. With several reports demonstrating that IFs may serve as "docking sites" for important kinases that recognize key cellular substrates, 17, 18, 108, 115, 122 it is clear that GFAP helps to form a dynamic continuum with microfilaments, integrin receptors, and the ECM. Studies aimed at delineating how this continuum is affected by GFAP expression would be of great value in increasing our understanding of the role GFAP plays in modulating cell morphology and signaling pathways.
